|
|
Immuron Limited's Yearly Net Cash Flow Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
IMRN Annual Net Cash Flow Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Net Cash Flow Change |
-11.73 % |
670.57 % |
-36.51 % |
8.3 % |
18.34 % |
Annual Net Cash Flow (in millions $) |
$22.11 |
$25.05 |
$3.25 |
$5.12 |
$4.73 |
Annual Net Cash Flow Growth
Comment |
Immuron Limited experienced detoriation of Annual Net Cash Flow for the fiscal year ended 2023 by -11.73% to $ 22.11 millions, compare to $ 25.05 in Annual Net Cash Flow reported in the previous year. The decline in company's annual Net Cash Flow accelerated, from the 670.57 % gain, in the fiscal year ended 2022.
Immuron Limited Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Net Cash Flow within Healthcare Sector | Y/Y Net Cash Flow Growth % | 2023 Annual Net Cash Flow | Vertex Pharmaceuticals Inc | | | |